Natco Pharma Schedules Investor Meeting at Investec Confluence in Pune
Natco Pharma Ltd 路 Intimation 路 17 Nov 2026, 12:23 am
Natco Pharma Schedules Investor Meeting at Investec Confluence in Pune Natco Pharma Limited announced that company officials will participate in an in-person, group investor meeting at the Investec Confluence on 19th Nov'26 in Pune, scheduled from 9:00 AM to 2:00 PM. The company confirmed that no Unpublished Price Sensitive Information (UPSI) will be discussed during these interactions. The schedule remains subject to changes based on exigencies from either party.
Original exchange filing (PDF)
More announcements from Natco Pharma Ltd
- Audio link of Earnings Conference Call Q2FY27 路 14 Nov 2026
- Q2 FY27 Earnings Presentation 路 13 Nov 2026
- Un audited Financial Results for the quarter and half year ended 30th September, 2026 路 13 Nov 2026
- 19th November, 2026 is the Record Date for the payment of 2nd Interim Dividend for FY 2026-27 路 13 Nov 2026
- Natco Pharma Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026 and declaration of 2nd Interim Dividend for FY 2026-27 路 13 Nov 2026
- Outcome of Board Meeting 路 13 Nov 2026
- Intimation of schedule of Concall 路 13 Nov 2026
- The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on November 04, 2026 for V C Nannapaneni 路 04 Nov 2026
